Precisio Biotix Therapeutics is US incorporated industry leader in precision antibacterial biological solutions; specifically the identification and development of lysin and phage products to combat bacterial infections or difficult to treat bacterial issues.
Products created with lysins and phages are novel precision solutions to address the declining effectiveness of existing treatments.
LysiThru™,the Company's industry-leading, high-throughput lysin screening system, is capable of rapidly creating new gram-positive and gram-negative lysins for almost every pathogen.
The Company has a robust pipeline of commercial products with both Rx and consumer commercial opportunities.
- Multiple gram positive and gram negative systemic lysins, with a focus on skin and lung infections.
- Bactelide™, a sustained release biodegradable phage product to prevent and treat topical infections
- Several topical lysins with consumer-oriented uses
Company Details
- Employees
- 8
- Address
- Dover, Delaware, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.precisiobiotix.com/
- Keywords
- High-throughput Lysin Screening System, Sustained Release Biodegradable Phage Product, Lysin and Phage Product.
- HQ
- Dover, Delaware
Precisio Biotix Questions
Precisio Biotix's website is http://www.precisiobiotix.com/
Precisio Biotix's LinkedIn profile is https://www.linkedin.com/company/precisio-biotix
Precisio Biotix has
8 employees.
View email and phone details for 8
employees at Precisio Biotix.
Precisio Biotix's industry is
Biotechnology Research
Precisio Biotix's top competitors are
Bluerock Therapeutics,
Cc Bio,
Corrixr Therapeutics,
Foresee Pharmaceuticals,
Eilean Therapeutics,
Altamira Therapeutics,
Qeen Biotechnologies,
Phagelux Agrihealth Inc.,
Unison Medicines,inc,
Ancilia Biosciences.
Precisio Biotix's categories are Biotechnology Research
